{
  "doc_id": "Atransferrinemia",
  "doc_filename": "Atransferrinemia.pdf",
  "top_entities": [
    {
      "name": "atransferrinemia",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "rare disorder",
      "mention_count": 1,
      "entity_type": "disease"
    }
  ],
  "file_size_bytes": 1854,
  "file_size_human": "1.8 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:17",
  "doi": null,
  "doi_url": null,
  "document_type_code": "CRM",
  "document_type_name": "Clinical Research Materials",
  "document_type_group": "Clinical Research Materials",
  "classification_confidence": 0.15,
  "title": "Atransferrinemia: A Rare Genetic Disorder",
  "short_description": "Clinical overview of atransferrinemia, an extremely rare disorder with only 10 reported cases in 8 families worldwide.",
  "long_description": "This document provides a comprehensive clinical overview of atransferrinemia, an exceptionally rare genetic disorder that affects iron transport in the body. The text discusses the epidemiology, noting that approximately 10 cases have been documented across 8 families since its first description in 1961. The document emphasizes the diagnostic challenges associated with this condition, as it may be unrecognized or misdiagnosed, making it difficult to determine its true prevalence. It outlines the diagnostic approach, which relies on identifying characteristic symptoms, obtaining detailed patient histories, conducting thorough clinical evaluations, and performing specialized laboratory tests that reveal low or undetectable transferrin levels in the blood. The disorder affects both males and females equally.",
  "document_date": "2026-01-07T22:25:17",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-04T16:22:37.583453"
}